Clinical Research Directory
Browse clinical research sites, groups, and studies.
Short-Term Metformin Use in Young, Healthy Adults: Impacts on Exercise Capacity
Sponsor: University of Virginia
Summary
Metformin is the most prescribed blood sugar (glucose)-lowering medication for patients diagnosed with type 2 diabetes mellitus (T2DM). Metformin stimulates glucose uptake in skeletal muscle similar to the effects of exercise, though, some studies report that metformin may decrease exercise capacity. The main question this study looks to answer is: • Does metformin alter exercise capacity? Participants will: * Complete 5 exercise tests on a stationary bike. * Undergo a body composition test. * Take metformin and placebo. * Complete food and symptom logs. The researchers hypothesize that: • Metformin will reduce aerobic capacity.
Official title: Short-Term Metformin Use in Young, Healthy Adults: Impacts on the Blood Lactate Response to Exercise and Time-to-exhaustion in a Placebo-controlled, Crossover Study
Key Details
Gender
All
Age Range
18 Years - 30 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2025-01-31
Completion Date
2026-04-01
Last Updated
2025-12-18
Healthy Volunteers
Yes
Conditions
Interventions
Metformin Hydrochloride
Participants will consume metformin or placebo in a randomized order. Participants will complete exercise visits during each treatment phase.
Placebo
Participants will consume metformin or placebo in a randomized order. Participants will complete exercise visits during each treatment phase.
Locations (1)
University of Virginia
Charlottesville, Virginia, United States